Аn overview of cardiovascular risks in patients with type 2 diabetes receiving glibenclamide

Медицинский совет

E. A. Ermakova¹  N. A. Chernikova¹ 

[1] the Russian Medical Academy of Postgraduate Education;

关键词: diabetes mellitus;    vascular complications;    antihyperglycemic drugs;    glibenclamide;    сахарный диабет;    сосудистые осложнения;    сахароснижающие препараты;    глибенкламид;   

DOI  :  10.21518/2079-701X-2013-9-70-75

来源: DOAJ

【 摘 要 】

Diabetes mellitus type 2 is a chronic progressive disease which leads to specific vascular complications - microangiopathy and macroangiopathy. These complications are the reason of increased cardiovascular mortality, which is 4-5 times higher in patients with type 2 diabetes mellitus than in the general population.

【 授权许可】

Unknown